Allergy CE-Mark and first Purchase Order

RNS Number : 0735C

Omega Diagnostics Group PLC

27 September 2018

 

Omega Diagnostics Group PLC

("Omega" or the "Company")

Allergy CE-Mark and first Purchase Order

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has CE-Marked five additional allergens, extending the menu to 58 allergens which can be run on the fully automated IDS Instrument.

These allergens will be supplied to IDS under the global distribution agreement announced on 20 April 2018.  Ongoing investment to increase the menu is supported by the research and development grant of up to £1.8 million, which the Company secured from Scottish Enterprise in August 2016.

The Company also confirms that commercialisation activities with IDS are proceeding to plan and that it has received its first purchase order which it will supply by the end of October. The size of the order is in line with the Company's expectation, whereby sales are expected to be modest during the initial launch phase.

Contacts:

Omega Diagnostics Group PLC	Tel: [phone]
Colin King, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
finnCap Ltd	Tel: [phone]
Geoff Nash/James Thompson (Corporate Finance)
Camille Gochez (Corporate Broking)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

 

END

 

 

MSCLFMFTMBITBJP